XML 34 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating Activities    
Net income $ 47,389 $ 36,801
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 1,030 958
Net amortization of investments 12,295 11,336
Deferred income taxes (752) (3,616)
Net realized (gains)/losses on investments 2,518 (181)
Net realized losses on sale of fixed assets 24  
Share-based compensation 691 988
Changes in operating assets and liabilities:    
Premiums receivable, net (15,169) (22,036)
Accrued interest receivable (571) (26)
Deferred policy acquisition costs (1,440) (1,845)
Amounts held by others (27,847) (1,081)
Other assets (1,712) (2,669)
Reserves for loss and loss adjustment expenses 33,108 62,052
Unearned premiums 7,694 14,153
Reinsurance balances (5,773) (13,817)
Amounts held for others and policyholder deposits 5,682 9,423
Accounts payable and other liabilities 5,555 12,354
Net cash provided by operating activities 62,722 102,794
Investing Activities    
Purchases of investments held-to-maturity (145,771) (151,608)
Purchases of investments available-for-sale (114,406) (104,172)
Purchases of short-term investments (7,000) (72,900)
Proceeds from maturities of investments held-to-maturity 115,656 79,042
Proceeds from sales and maturities of investments available-for-sale 70,652 42,633
Proceeds from sales and maturities of short-term investments 33,341 112,652
Purchases of property and equipment (759) (771)
Net cash used in investing activities (48,287) (95,124)
Financing Activities    
Proceeds from stock option exercises 1,277 1,820
Tax benefit from share-based payments 1,795 1,975
Dividends to stockholders (8,564) (15,998)
Net cash used in financing activities (5,492) (12,203)
Change in cash and cash equivalents 8,943 (4,533)
Cash and cash equivalents at beginning of period 90,956 123,077
Cash and cash equivalents at end of period $ 99,899 $ 118,544